CD168 Primary Antibody

Item Information
Catalog #Size/ConcentrationPrice
Specification
AliasesHMMR; IHABP; RHAMM
ProductOrderC
Clone#2F2C9
Entrez GenelD3161
FormulationPurified antibody in PBS with 0.05% sodium azide
HostMouse
IsotypeIgG1
ImmunogenPurified recombinant fragment of human CD168 (AA: 306-497 ) expressed in E. Coli.
MW84.1kDa
Shipping InformationThis product will ship in a box containing blue ice at a temperature of 4°C. Learn More
Species ReactivityHuman
Application
ELISA1/10000
FCM (Flow Cytometry)1/200 - 1/400
WB (Western Blot)1/500 - 1/2000
Sequence
306-497
Catalog#: 30807
Inquire
Contact us to order
Images
Elisa
Figure 1: Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Figure 1: Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Western Blot
Figure 2:Western blot analysis using CD168 mAb against human CD168 (AA: 306-497) recombinant protein. (Expected MW is 48.3 kDa)
Figure 2:Western blot analysis using CD168 mAb against human CD168 (AA: 306-497) recombinant protein. (Expected MW is 48.3 kDa)
Western Blot
Figure 3:Western blot analysis using CD168 mAb against HEK293 (1) and CD168 (AA: 306-497)-hIgGFc transfected HEK293 (2) cell lysate.
Figure 3:Western blot analysis using CD168 mAb against HEK293 (1) and CD168 (AA: 306-497)-hIgGFc transfected HEK293 (2) cell lysate.
Flow cytometric
Figure 4:Flow cytometric analysis of Hela cells using CD168 mouse mAb (green) and negative control (red).
Figure 4:Flow cytometric analysis of Hela cells using CD168 mouse mAb (green) and negative control (red).
Product Overview
DescriptionThe protein encoded by this gene is involved in cell motility. It is expressed in breast tissue and together with other proteins, it forms a complex with BRCA1 and BRCA2, thus is potentially associated with higher risk of breast cancer. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.
References (references)
References (references)1.PLoS One. 2013 Sep 17;8(9):e75681.
2.BMC Cancer. 2011 Mar 24;11:106.